Naomi Ohshiro

519 citations
11 papers · 414 indexed · h-index 8
Topics
Drug Transport and Resistance Mechanisms (11 papers)Pharmacogenetics and Drug Metabolism (5 papers)Metabolism and Genetic Disorders (5 papers)
Partner nations
JapanUnited States

In The Last Decade

Naomi Ohshiro

11 papers receiving 402 citations

Peers

Naomi Ohshiro
Comparison fields: 5 of 69
  • Oncology 310
  • Pediatrics, Perinatology and Child Health 133
  • Molecular Biology 113
  • Pharmacology 91
  • Clinical Biochemistry 57
Replace Noriko Kohyama with:
Noriko Kohyama Japan
Habib Hasannejad Japan
Ahsan Rizwan Germany
Katja Damme Germany
G M Groothuis Netherlands
Reno Z. Vlahcevic United States
Sumito Ito Japan
Takehisa Matsumaru Japan
T. Tokui Japan
Naoyo Sano Japan
Naomi Ohshiro relative to Noriko Kohyama Japan Noriko Kohyama's profile →
Citations per field
00.5×1.5×
Noriko Kohyama · 1×
Citations per year

Countries citing papers authored by Naomi Ohshiro

Since Specialization
Citations

This map shows the geographic impact of Naomi Ohshiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Ohshiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Ohshiro more than expected).

Fields of papers citing papers by Naomi Ohshiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naomi Ohshiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Ohshiro. The network helps show where Naomi Ohshiro may publish in the future.

Co-authorship network of co-authors of Naomi Ohshiro

This figure shows the co-authorship network connecting the top 25 collaborators of Naomi Ohshiro. A scholar is included among the top collaborators of Naomi Ohshiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi Ohshiro. Naomi Ohshiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 31
2 42
3 135
4 39
5 68
6 11
7 61
8 11
9 3
10 7
11 6

About Naomi Ohshiro

Naomi Ohshiro is a scholar working on Clinical Biochemistry, Pharmacology and Oncology, having authored 11 papers that have together received 414 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (11 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Metabolism and Genetic Disorders (5 papers). The work is most often cited by research in Oncology (310 citations), Pharmacology (91 citations) and Clinical Biochemistry (57 citations). Naomi Ohshiro has collaborated with scholars based in Japan and United States. Frequent co-authors include Toshinori Yamamoto, Yasuna Kobayashi, Noriko Kohyama, Masayuki Ohbayashi, Ryoko Sakai, Shogo Tokuyama, Tadanori Sasaki, Takashi Sekine, Hitoshi Endou and Hironori Saito. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026